Company
Vireo Growth Inc. (VREOF)
Standardized SEC financial data for Vireo Growth Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001771706 · OTC · Pharmaceutical Preparations.
Gross margin
47.3%
Operating margin
-0.4%
Net margin
-25.3%
Revenue growth (YoY)
170.4%
Return on equity
-22.2%
ROIC
-0.3%
Free cash flow
-$24.6M
Debt / equity
0.23×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $49.2M | $54.4M | $74.6M | $88.1M | $99.4M | $268.8M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $27.1M | $15.2M | $15.1M | $16.0M | $91.6M | $122.5M |
| Accounts receivable |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$10.9M | -$30.5M | -$18.1M | -$966K | -$10.2M | $3.7M |
| Capital expenditures |
Get VREOF data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/VREOF/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/VREOF/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"